The authors review new regulatory expectations and describe potential approaches to accommodate excipient variability. This article is part of PharmTech's supplement "Solid Dosage and Excipients 2010.
Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. The company’s portfolio ...
Since the United States Pharmacopeia (USP) and National Formulary (NF) General Notices combined, it could be interpreted that API requirements apply to excipients. In USP–NF General Notices, an API ...
Excipients, the ‘inactive’ substances that are mixed with active pharmaceutical ingredients to achieve drug formulation requirements, don’t get much love. But with innovations in medicinal chemistry ...
FDA is launching a program to test the safety and suitability of novel inactive ingredients for use in new drugs and biologics. In an important step for modernizing drug formulation and ...
Dublin, Aug. 12, 2020 (GLOBE NEWSWIRE) -- The "Analysis of the Global Oral Solid Dosage Excipients Market, Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. Excipients have ...
The purpose of formulation development is to ensure that the drug is safe, effective, stable, and convenient to use. If the dosage form is improperly selected and if the prescription and process ...
As per the International Pharmaceuticals Excipients Council “Pharmaceutical excipients are substances other than the active pharmaceutical ingredient (API) that have been appropriately evaluated for ...
When it comes to drugs, most of the attention goes to the active pharmaceutical ingredient. But typically the vast majority of what’s in a tablet, capsule, or liquid isn’t the active ingredient. A ...
The Pharmaceutical Excipients Market is poised for significant growth between 2025 and 2035, driven by the increasing demand for drug formulations and advancements in the pharmaceutical industry.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback